Article History
Received: 5 March 2024
Revised: 2 May 2024
Accepted: 8 May 2024
First Online: 13 May 2024
Declarations
:
: Yawara Kawano has received research funding from Sebia, has received honoraria from Janssen Pharmaceuticals Inc, Sebia, Ono Pharmaceutical, Takeda Pharmaceutical Co. Ltd., Bristol Myers Squibb Co., and Sanofi and has served on Advisory Board for Bristol Myers Squibb Co. Nao Nishimura and Jun-ichirou Yasunaga have nothing to disclose.